Brain–machine interfaces (BMIs) have the potential to restore functions in people with neurological disorders, but they face challenges in development, ethics and implementation. As the field progresses and approaches clinical translation, addressing issues of hype, patient access, user-centred design and long-term support will be essential to ensure responsible innovation and adoption of BMIs.